Not only that several of the posters who came here from the raging bull board happened to listen to a local radio stock show host who got the stock from a promo which happened to be around the time of the reverse split and Jade. If I hadn't been doing the research on Jade and calling into the show, the stock likely would have never hit 4 bucks. When Jade quit responding to Dreher's requests and they couldn't use the Jade China facility for an asset based loan and were forced into that bad convertible, most of us felt the party was over as we gave little to any value in DR-70. I was all about JPGreen however. JMHO
"This message board was started for RPC when the company changed their name from AMDL to RPC in October 2006. Before that, there were AMDL boards. Nobody created a message board because of a Jade filing."
Lakeshore, You are mistaken. The change from AMDL to RPC was in 2009 and not 2006 as you stated...Here is a link to prove my stance..Wolf bing bing ahooooooo
Radient Pharmaceuticals: New Name, New Focus By By Ed Rabinowitz | May 19, 2010
Executives at Radient Pharmaceuticals Corporation may one day look back on 2009 as the year when the coming-out party for the two-decades-old firm located in Tustin, California, began. Until last fall, the company focused largely on the production and distribution of pharmaceutical products through its subsidiaries in the People’s Republic of China. That changed on September 18, 2009, when the firm refocused its core business strategy on the international commercialization of its Onko-Sure In Vitro Diagnostic (IVD) Cancer Test Kits and, to a lesser extent, Elleuxe skin care products.
“What we’ve really determined is that focusing on a much narrower path of being a cancer diagnostic company, or an IVD company, is the strongest path for us,” said company chairman and CEO Douglas MacLellan. In addition to changing its focus, the company also changed its name from American Medical Diagnostics Lab (AMDL) to the current Radient Pharmaceuticals.
News 
Market Data 
Discover 
